speb/financial-data huggingface dataset:
Financial ratios for SUN — quarterly report dated 2025-06-30
Total revenue: 5390000000
Gross profit: 415000000
Operating income: 201000000
Net income: 86000000
Capital expenditures: 5000000
Operating cash flow: 243000000
Depreciation & amortization: 154000000
Net tangible assets: 2087000000
Owner earnings: 235000000
Return on net tangible assets (%): 11.26018207954001
Capex to operating income (%): 2.4875621890547266
Buffett classification: The Great
Stock price: 50.18
P/E ratio: 23.444978688464165
Shares outstanding: 136894754
Book value: 4097000000
P/B ratio: 1.6766850758408591
Market cap (USD): 6869378755.72
Debt to equity: 2.036612155235538
Current ratio: 1.5226993865030676
Quick ratio: 0.7993865030674847
Effective tax rate (%): 7.526881720430108
Interest coverage ratio: 1.6341463414634145
COGS to revenue (%): 92.30055658627087
SG&A to revenue (%): 1.280148423005566
Free cash flow (dilution-adjusted): 78000000
Buyback yield (%): 0
Inventory turnover: 4.219677692960135
Receivables turnover: 5.197685631629701
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5705578996718237
FCF margin (%): 1.4471243042671615
Revenue growth (%): 4.0741455879513415
Rule of 40 score: 5.521269892218503
Financial ratios for SUN — quarterly report dated 2025-09-30
Total revenue: 6032000000
Gross profit: 487000000
Operating income: 255000000
Net income: 137000000
Capital expenditures: 3000000
Operating cash flow: 401000000
Depreciation & amortization: 159000000
Net tangible assets: 3538000000
Owner earnings: 293000000
Return on net tangible assets (%): 8.28151498021481
Capex to operating income (%): 1.1764705882352942
Buffett classification: The Great
Stock price: 47.66
P/E ratio: 15.17303250148837
Shares outstanding: 136894754
Book value: 5541000000
P/B ratio: 1.177477707208085
Market cap (USD): 6524403975.639999
Debt to equity: 1.8179029056127052
Current ratio: 3.113551151580075
Quick ratio: 2.5013390465988214
Effective tax rate (%): 7.4324324324324325
Interest coverage ratio: 1.9465648854961832
COGS to revenue (%): 91.9263925729443
SG&A to revenue (%): 1.160477453580902
Free cash flow (dilution-adjusted): 239000000
Buyback yield (%): 0
Inventory turnover: 4.851268591426072
Receivables turnover: 4.573161485974223
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5959444235824258
FCF margin (%): 3.9622015915119366
Revenue growth (%): 11.910946196660483
Rule of 40 score: 15.87314778817242
Financial ratios for SUN — annual report dated 2025-12-31
Total revenue: 25201000000
Gross profit: 2104000000
Operating income: 929000000
Net income: 527000000
Capital expenditures: 28000000
Operating cash flow: 1192000000
Depreciation & amortization: 688000000
Net tangible assets: 2572000000
Owner earnings: 1187000000
Return on net tangible assets (%): 46.15085536547434
Capex to operating income (%): 3.013993541442411
Buffett classification: The Great
Stock price: 50.82
P/E ratio: 13.201122197874762
Shares outstanding: 136894754
Book value: 8009000000
P/B ratio: 0.8686466972505931
Market cap (USD): 6956991398.28
Debt to equity: 1.854788363091522
Current ratio: 1.3800350262697023
Quick ratio: 0.7838378784088066
Effective tax rate (%): 10.526315789473683
Interest coverage ratio: 1.736448598130841
COGS to revenue (%): 91.65112495535891
SG&A to revenue (%): 1.6269195666838618
Free cash flow (dilution-adjusted): 596000000
Buyback yield (%): 0
Inventory turnover: 9.692404532102392
Receivables turnover: 12.779411764705882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.812846295916273
FCF margin (%): 2.36498551644776
Revenue growth (%): 11.05186621425109
Rule of 40 score: 13.41685173069885
Financial ratios for SUN — quarterly report dated 2025-12-31
Total revenue: 8600000000
Gross profit: 705000000
Operating income: 174000000
Net income: 97000000
Capital expenditures: 17000000
Operating cash flow: 392000000
Depreciation & amortization: 219000000
Net tangible assets: 2572000000
Owner earnings: 299000000
Return on net tangible assets (%): 11.625194401244169
Capex to operating income (%): 9.770114942528735
Buffett classification: The Great
Stock price: 50.82
P/E ratio: 13.201122197874762
Shares outstanding: 136894754
Book value: 8009000000
P/B ratio: 0.8686466972505931
Market cap (USD): 6956991398.28
Debt to equity: 1.854788363091522
Current ratio: 1.3800350262697023
Quick ratio: 0.7838378784088066
Effective tax rate (%): 32.16783216783217
Interest coverage ratio: 1.0875
COGS to revenue (%): 91.80232558139535
SG&A to revenue (%): 2.511627906976744
Free cash flow (dilution-adjusted): 228000000
Buyback yield (%): 0
Inventory turnover: 3.313050776332354
Receivables turnover: 4.36105476673428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7141391340036938
FCF margin (%): 2.6511627906976742
Revenue growth (%): 42.57294429708223
Rule of 40 score: 45.224107087779906
Financial ratios for SWN.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.48863636363636
Shares outstanding: 489208201
Market cap (USD): 20296581157.397724
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SWN.DE — annual report dated 2022-12-31
Total revenue: 23814000000
Gross profit: 4752000000
Operating income: 1017000000
Net income: 561000000
Capital expenditures: 22000000
Operating cash flow: 3790000000
Depreciation & amortization: 1351000000
Net tangible assets: 9421000000
Owner earnings: 1890000000
Return on net tangible assets (%): 20.06156458974631
Capex to operating income (%): 2.1632251720747298
Buffett classification: The Great
Stock price: 32.54901960784314
P/E ratio: 28.383685074272137
Shares outstanding: 489208201
Book value: 10687000000
P/B ratio: 1.489964192632794
Market cap (USD): 15923247326.66667
Debt to equity: 0.8824740338729298
Current ratio: 1.4268645211023319
Quick ratio: 1.3507419541337444
Effective tax rate (%): 25.961538461538463
Interest coverage ratio: 3.3787375415282392
COGS to revenue (%): 80.04535147392289
Free cash flow (dilution-adjusted): -156000000
Buyback yield (%): 0
Retained earnings: 16261000000
Inventory turnover: 24.129113924050632
Receivables turnover: 23.67196819085487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.069465007402665
FCF margin (%): -0.655076845553036
Rule of 40 score: -0.655076845553036
Financial ratios for SWN.DE — annual report dated 2023-12-31
Total revenue: 26091000000
Gross profit: 4223000000
Operating income: 224000000
Net income: 484000000
Capital expenditures: 0
Operating cash flow: 3164000000
Depreciation & amortization: 1522000000
Net tangible assets: 9249000000
Owner earnings: 2006000000
Return on net tangible assets (%): 21.688831224997294
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.54901960784314
P/E ratio: 32.89927133608816
Shares outstanding: 489208201
Book value: 10515000000
P/B ratio: 1.5143364076715806
Market cap (USD): 15923247326.66667
Debt to equity: 0.874940561103186
Current ratio: 1.1386259791122715
Quick ratio: 1.072780678851175
Effective tax rate (%): 26.540284360189574
Interest coverage ratio: 0.9491525423728814
COGS to revenue (%): 83.81434211030624
Free cash flow (dilution-adjusted): -356000000
Buyback yield (%): 0
Retained earnings: 16297000000
Inventory turnover: 27.097893432465924
Receivables turnover: 22.84676007005254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9244356402954892
FCF margin (%): -1.3644551761143688
Revenue growth (%): 9.561602418745276
Rule of 40 score: 8.197147242630907
Financial ratios for SWN.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.54901960784314
Shares outstanding: 489208201
Market cap (USD): 15923247326.66667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SWN.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.54901960784314
Shares outstanding: 489208201
Market cap (USD): 15923247326.66667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SWN.DE — annual report dated 2024-12-31
Total revenue: 27483000000
Gross profit: 4459000000
Operating income: 321000000
Net income: 485000000
Capital expenditures: 871000000
Operating cash flow: 462000000
Depreciation & amortization: 1657000000
Net tangible assets: 9080000000
Owner earnings: 1271000000
Return on net tangible assets (%): 13.997797356828192
Capex to operating income (%): 271.33956386292834
Buffett classification: The Gruesome
Stock price: 32.54901960784314
P/E ratio: 32.831437786941585
Shares outstanding: 489208201
Book value: 10350000000
P/B ratio: 1.53847800257649
Market cap (USD): 15923247326.66667
Debt to equity: 0.7785507246376812
Current ratio: 0.918377321603128
Quick ratio: 0.8532095144998371
Effective tax rate (%): 22.240802675585282
Interest coverage ratio: 1.5
COGS to revenue (%): 83.77542480806316
Free cash flow (dilution-adjusted): -1592000000
Buyback yield (%): 1.5700315072122561
Retained earnings: 16332000000
Inventory turnover: 28.78
Receivables turnover: 24.781785392245265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4948309583682593
FCF margin (%): -5.792671833497071
Revenue growth (%): 5.335173048177532
Rule of 40 score: -0.45749878531953847
Financial ratios for SWN.DE — quarterly report dated 2025-03-31
Total revenue: 6428000000
Gross profit: 867000000
Operating income: -223000000
Net income: -149000000
Capital expenditures: 50000000
Operating cash flow: 860000000
Depreciation & amortization: 396000000
Net tangible assets: 8096000000
Owner earnings: 197000000
Buffett classification: The Gruesome
Stock price: 32.54901960784314
Shares outstanding: 489208201
Book value: 9365000000
P/B ratio: 1.7002933610962807
Market cap (USD): 15923247326.66667
Debt to equity: 0.8537106246663108
Current ratio: 0.7721746636932595
Quick ratio: 0.7156319689230991
Interest coverage ratio: -6.371428571428571
COGS to revenue (%): 86.51213441194773
Free cash flow (dilution-adjusted): 333000000
Buyback yield (%): 4.710094521636768
Retained earnings: 16080000000
Inventory turnover: 7.075063613231552
Receivables turnover: 5.962894248608534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1547822484594272
FCF margin (%): 5.180460485376478
Rule of 40 score: 5.180460485376478
Financial ratios for SWN.DE — quarterly report dated 2025-06-30
Total revenue: 7244000000
Gross profit: 1358000000
Operating income: 225000000
Net income: 213000000
Capital expenditures: 25000000
Operating cash flow: 401000000
Depreciation & amortization: 400000000
Net tangible assets: 6735000000
Owner earnings: 588000000
Return on net tangible assets (%): 8.730512249443208
Capex to operating income (%): 11.11111111111111
Buffett classification: The Great
Stock price: 32.54901960784314
P/E ratio: 248.8007394791667
Shares outstanding: 489208201
Book value: 8000000000
P/B ratio: 1.9904059158333336
Market cap (USD): 15923247326.66667
Debt to equity: 0.667625
Current ratio: 0.559309585016526
Quick ratio: 0.48834006610356223
Effective tax rate (%): 23.92857142857143
Interest coverage ratio: 8.653846153846153
COGS to revenue (%): 81.25345113197129
Free cash flow (dilution-adjusted): -259000000
Buyback yield (%): 9.420189043273536
Retained earnings: 16199000000
Inventory turnover: 7.614489003880983
Receivables turnover: 7.151036525172755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2626262626262625
FCF margin (%): -3.5753727222528986
Revenue growth (%): 12.69446172993155
Rule of 40 score: 9.119089007678651
Financial ratios for SWN.DE — quarterly report dated 2025-09-30
Total revenue: 6949000000
Gross profit: 1158000000
Operating income: 35000000
Net income: 54000000
Capital expenditures: 0
Operating cash flow: 287000000
Depreciation & amortization: 394000000
Net tangible assets: 6511000000
Owner earnings: 448000000
Return on net tangible assets (%): 6.880663492551068
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 40.68235294117647
P/E ratio: 168.6622092779661
Shares outstanding: 489208201
Book value: 7776000000
P/B ratio: 2.5594316737139917
Market cap (USD): 19902140694.8
Debt to equity: 0.6761831275720165
Current ratio: 0.4907222121156995
Quick ratio: 0.4186829179552483
Effective tax rate (%): 20.588235294117645
Interest coverage ratio: 1.5909090909090908
COGS to revenue (%): 83.33573175996546
Free cash flow (dilution-adjusted): -391000000
Buyback yield (%): 1.256146280110057
Retained earnings: 16158000000
Inventory turnover: 7.311868686868687
Receivables turnover: 6.215563506261181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.20210185933710592
FCF margin (%): -5.626708878975392
Revenue growth (%): -4.072335726118167
Rule of 40 score: -9.699044605093558
Financial ratios for SWN.DE — annual report dated 2025-12-31
Total revenue: 28063000000
Gross profit: 4895000000
Operating income: 428000000
Net income: 442000000
Capital expenditures: 24000000
Operating cash flow: 1842000000
Depreciation & amortization: 1560000000
Net tangible assets: 6715000000
Owner earnings: 1978000000
Return on net tangible assets (%): 29.45644080416977
Capex to operating income (%): 5.607476635514018
Buffett classification: The Great
Stock price: 40.76470588235294
P/E ratio: 45.11861635520362
Shares outstanding: 489208201
Book value: 7981000000
P/B ratio: 2.4987380565092097
Market cap (USD): 19942428429
Debt to equity: 0.7494048364866558
Current ratio: 0.5168940573207582
Quick ratio: 0.4459298599029393
Effective tax rate (%): 21.6696269982238
Interest coverage ratio: 3.7876106194690267
COGS to revenue (%): 82.55710365962298
Free cash flow (dilution-adjusted): -831000000
Buyback yield (%): 12.786807830744554
Retained earnings: 16388000000
Inventory turnover: 29.894193548387097
Receivables turnover: 24.42384682332463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3594266813671445
FCF margin (%): -2.9611944553326444
Revenue growth (%): 2.1103955172288322
Rule of 40 score: -0.8507989381038121
Financial ratios for SWN.DE — quarterly report dated 2025-12-31
Total revenue: 7442000000
Gross profit: 1512000000
Operating income: 391000000
Net income: 324000000
Capital expenditures: 1000000
Operating cash flow: 295000000
Depreciation & amortization: 371000000
Net tangible assets: 6715000000
Owner earnings: 694000000
Return on net tangible assets (%): 10.335070737155622
Capex to operating income (%): 0.2557544757033248
Buffett classification: The Great
Stock price: 40.76470588235294
P/E ratio: 45.11861635520362
Shares outstanding: 489208201
Book value: 7981000000
P/B ratio: 2.4987380565092097
Market cap (USD): 19942428429
Debt to equity: 0.7494048364866558
Current ratio: 0.5168940573207582
Quick ratio: 0.4459298599029393
Effective tax rate (%): 20.833333333333336
Interest coverage ratio: 12.612903225806452
COGS to revenue (%): 79.68288094598226
Free cash flow (dilution-adjusted): -564000000
Buyback yield (%): 0.2507217221714618
Retained earnings: 16388000000
Inventory turnover: 7.651612903225806
Receivables turnover: 6.476936466492602
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1554575523704522
FCF margin (%): -7.578607901101854
Revenue growth (%): 7.094545977838537
Rule of 40 score: -0.484061923263317
Financial ratios for SXTP — annual report dated 2023-12-31
Total revenue: 253573
Gross profit: -220977
Operating income: -5154583
Net income: -3765702
Capital expenditures: 57623
Operating cash flow: -4542910
Depreciation & amortization: 100372
Net tangible assets: 4642876
Owner earnings: -3722953
Return on net tangible assets (%): -80.18635432003784
Buffett classification: The Gruesome
Stock price: 244.8
Shares outstanding: 2659288
Book value: 4798096
P/B ratio: 135.6775067443419
Market cap (USD): 650993702.4
Debt to equity: 0.035987816834010825
Current ratio: 2.5543227397383954
Quick ratio: 2.389913818885641
Interest coverage ratio: -2.254220062038706
COGS to revenue (%): 187.14531909943094
R&D to revenue (%): 272.80901357794403
SG&A to revenue (%): 1672.8263655830865
Free cash flow (dilution-adjusted): -6394972
Buyback yield (%): 0
Retained earnings: -32580850
Inventory turnover: 1.0179784584560534
Receivables turnover: 1.0961432054363425
Capitalized R&D asset: 1043897.21
ROCI (R&D-adjusted, %): -81.2482017762535
Rosenberg metric: -0.02248065407952995
FCF margin (%): -2521.9451597764746
Revenue growth (%): 13.603903085910899
Rule of 40 score: -2508.3412566905636
Financial ratios for SXTP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25
Shares outstanding: 2659288
Market cap (USD): 66482200
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXTP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.8
Shares outstanding: 2659288
Market cap (USD): 68609630.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXTP — annual report dated 2024-12-31
Total revenue: 607574
Gross profit: 222809
Operating income: -9715181
Net income: -7947107
Capital expenditures: 103773
Operating cash flow: -5648088
Depreciation & amortization: 63745
Net tangible assets: 3878516
Owner earnings: -7987135
Return on net tangible assets (%): -205.9327588180634
Buffett classification: The Gruesome
Stock price: 25.8
Shares outstanding: 2659288
Book value: 3955006
P/B ratio: 17.347541419659038
Market cap (USD): 68609630.4
Debt to equity: 0.03941612225114197
Current ratio: 3.250188267097911
Quick ratio: 2.983015532035578
Interest coverage ratio: -1227.9045753286148
COGS to revenue (%): 63.32808843038049
R&D to revenue (%): 820.7273517299951
SG&A to revenue (%): 827.0984275166481
Free cash flow (dilution-adjusted): -9437850
Buyback yield (%): 0
Retained earnings: -40527957
Inventory turnover: 0.8690069653359351
Receivables turnover: 1.2482311175392606
Capitalized R&D asset: 5623447.69
ROCI (R&D-adjusted, %): -69.88388464761964
Rosenberg metric: 0.6415224713416309
FCF margin (%): -1553.366338915095
Revenue growth (%): 139.6051630102574
Rule of 40 score: -1413.7611759048375
Financial ratios for SXTP — quarterly report dated 2025-03-31
Total revenue: 163552
Gross profit: 90280
Operating income: -1910938
Net income: -1876549
Capital expenditures: 2678
Operating cash flow: -1597366
Depreciation & amortization: 16797
Net tangible assets: 3960450
Owner earnings: -1862430
Return on net tangible assets (%): -47.025716774608945
Buffett classification: The Gruesome
Stock price: 7.36
Shares outstanding: 2659288
Book value: 4028889
P/B ratio: 4.858004199172526
Market cap (USD): 19572359.68
Debt to equity: 0.03854015337727101
Current ratio: 3.1347052609854447
Quick ratio: 2.705718689180882
Interest coverage ratio: -1067.56312849162
COGS to revenue (%): 44.80043044414009
R&D to revenue (%): 226.7248336920368
SG&A to revenue (%): 1053.5707297984738
Free cash flow (dilution-adjusted): -1789611
Buyback yield (%): 0
Retained earnings: -42404506
Inventory turnover: 0.09475995747751663
Receivables turnover: 0.3349807370510176
Capitalized R&D asset: 370813
ROCI (R&D-adjusted, %): -36.596011382976506
FCF margin (%): -1094.2152954412052
Rule of 40 score: -1094.2152954412052
Financial ratios for SXTP — quarterly report dated 2025-06-30
Total revenue: 100932
Gross profit: 50881
Operating income: -1604828
Net income: -1733726
Capital expenditures: 47323
Operating cash flow: -1450128
Depreciation & amortization: 19678
Net tangible assets: 2284550
Owner earnings: -1761371
Return on net tangible assets (%): -77.09925368234445
Buffett classification: The Gruesome
Stock price: 9.48
Shares outstanding: 2659288
Book value: 2345704
P/B ratio: 10.747327983411376
Market cap (USD): 25210050.240000002
Debt to equity: 0.06575808371388718
Current ratio: 2.273747794626904
Quick ratio: 1.800929406177233
Interest coverage ratio: -1314.3554463554462
COGS to revenue (%): 49.5888320849681
R&D to revenue (%): 247.5765862164626
SG&A to revenue (%): 1597.8718345024372
Free cash flow (dilution-adjusted): -1492197
Buyback yield (%): 0
Retained earnings: -44138232
Inventory turnover: 0.0626090633095703
Receivables turnover: 0.3421029440674634
Capitalized R&D asset: 498328.71
ROCI (R&D-adjusted, %): -52.24411865181733
Rosenberg metric: -0.10625032024227846
FCF margin (%): -1478.4181429080966
Revenue growth (%): -38.28751711993739
Rule of 40 score: -1516.705660028034
Financial ratios for SXTP — quarterly report dated 2025-09-30
Total revenue: 437602
Gross profit: -100088
Operating income: -2325525
Net income: -2316324
Capital expenditures: 9999
Operating cash flow: -2109072
Depreciation & amortization: 22830
Net tangible assets: 4277837
Owner earnings: -2303493
Return on net tangible assets (%): -53.847142843451024
Buffett classification: The Gruesome
Stock price: 5.92
Shares outstanding: 2659288
Book value: 4346958
P/B ratio: 3.621609631379001
Market cap (USD): 15742984.959999999
Debt to equity: 0.035372782529759894
Current ratio: 2.8712233673160115
Quick ratio: 2.6313920034367984
Interest coverage ratio: -1361.5485948477751
COGS to revenue (%): 122.87192471698027
R&D to revenue (%): 185.04874292165027
SG&A to revenue (%): 344.2900169560468
Free cash flow (dilution-adjusted): -2301794
Buyback yield (%): 0
Retained earnings: -46454556
Inventory turnover: 1.0202768859439397
Receivables turnover: 0.6492264508127162
Capitalized R&D asset: 1099567.57
ROCI (R&D-adjusted, %): -35.63563275482414
Rosenberg metric: -0.6041563285364409
FCF margin (%): -526.001709315771
Revenue growth (%): 333.5612095272064
Rule of 40 score: -192.44049978856458
Financial ratios for SXTP — quarterly report dated 2025-12-31
Total revenue: 303385
Gross profit: 182703
Operating income: -1917351
Net income: -1438559
Capital expenditures: 79881
Operating cash flow: -1692456
Depreciation & amortization: 23567
Net tangible assets: 3238816
Owner earnings: -1494873
Return on net tangible assets (%): -46.15492204558703
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 2659288
Book value: 3379416
P/B ratio: 1.5974223475298688
Market cap (USD): 5398354.64
Debt to equity: 0.04520751514462854
Current ratio: 2.656558634940894
Quick ratio: 2.3000756460848537
Interest coverage ratio: -621.3062216461439
COGS to revenue (%): 39.778499266608435
R&D to revenue (%): 210.58160423224615
SG&A to revenue (%): 485.90899352308116
Free cash flow (dilution-adjusted): -1939848
Buyback yield (%): 0
Retained earnings: -47893115
Inventory turnover: 0.18370770439198447
Receivables turnover: 0.5952880834464842
Capitalized R&D asset: 1263885.31
ROCI (R&D-adjusted, %): -38.532248642451556
Rosenberg metric: 0.34922083487182276
FCF margin (%): -639.4014206371442
Revenue growth (%): -30.671020699174136
Rule of 40 score: -670.0724413363183
Financial ratios for SXTP — annual report dated 2025-12-31
Total revenue: 1005471
Gross profit: 223776
Operating income: -7758579
Net income: -7365158
Capital expenditures: 139881
Operating cash flow: -6849022
Depreciation & amortization: 82872
Net tangible assets: 3238816
Owner earnings: -7422167
Return on net tangible assets (%): -229.1629719008428
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 2659288
Book value: 3379416
P/B ratio: 1.5974223475298688
Market cap (USD): 5398354.64
Debt to equity: 0.04520751514462854
Current ratio: 2.656558634940894
Quick ratio: 2.3000756460848537
Interest coverage ratio: -994.0524023062139
COGS to revenue (%): 77.74416169138642
R&D to revenue (%): 209.46959186291795
SG&A to revenue (%): 624.5653032260502
Free cash flow (dilution-adjusted): -7523450
Buyback yield (%): 0
Retained earnings: -47893115
Inventory turnover: 1.1899321687135802
Receivables turnover: 1.9728889185392156
Capitalized R&D asset: 5675412.52
ROCI (R&D-adjusted, %): -89.65530366984409
Rosenberg metric: 0.00019392258257552451
FCF margin (%): -748.2513170444498
Revenue growth (%): 65.48947124136319
Rule of 40 score: -682.7618458030867
Financial ratios for TCBX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: -270000
Buffett classification: The Gruesome
Stock price: 25.98
Shares outstanding: 16592071
Market cap (USD): 431062004.58
Buyback yield (%): 0.028070207699677656
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBX — annual report dated 2022-12-31
Total revenue: 122689000
Net income: 18659000
Capital expenditures: 10863000
Operating cash flow: 21791000
Depreciation & amortization: 2555000
Net tangible assets: 362615000
Owner earnings: 10351000
Return on net tangible assets (%): 2.8545426967996357
Buffett classification: The Gruesome
Stock price: 18.43
P/E ratio: 16.388438208371294
Shares outstanding: 16592071
Book value: 381780000
P/B ratio: 0.8009635615537744
Market cap (USD): 305791868.53
Debt to equity: 0.339022473675939
Effective tax rate (%): 19.462189226519335
COGS to revenue (%): 0
SG&A to revenue (%): 47.61796086038683
Free cash flow (dilution-adjusted): 8327000
Buyback yield (%): 0
Retained earnings: 53270000
Receivables turnover: 6.68969465648855
Capitalized R&D asset: 0
FCF margin (%): 6.7870795262819
Rule of 40 score: 6.7870795262819
Financial ratios for TCBX — annual report dated 2023-12-31
Total revenue: 147057000
Net income: 33401000
Capital expenditures: 3437000
Operating cash flow: 39075000
Depreciation & amortization: 3946000
Net tangible assets: 392971000
Owner earnings: 33910000
Return on net tangible assets (%): 8.629135483279937
Buffett classification: The Gruesome
Stock price: 19.87
P/E ratio: 9.870496415376785
Shares outstanding: 16592071
Book value: 411974000
P/B ratio: 0.8002554791564517
Market cap (USD): 329684450.77000004
Debt to equity: 0.343973163354969
Effective tax rate (%): 19.732288762856868
COGS to revenue (%): 0
SG&A to revenue (%): 44.094466771387964
Free cash flow (dilution-adjusted): 34010000
Buyback yield (%): 0
Retained earnings: 78775000
Receivables turnover: 6.360596885813149
Capitalized R&D asset: 0
FCF margin (%): 23.12708677587602
Revenue growth (%): 19.861601284548737
Rule of 40 score: 42.98868806042476
Financial ratios for TCBX — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: -1002000
Buffett classification: The Gruesome
Stock price: 26.77
Shares outstanding: 16592071
Market cap (USD): 444169740.67
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.95
Shares outstanding: 16592071
Market cap (USD): 563300810.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCBX — annual report dated 2024-12-31
Total revenue: 170475000
Net income: 47671000
Capital expenditures: 1766000
Operating cash flow: 35136000
Depreciation & amortization: 4620000
Net tangible assets: 441878000
Owner earnings: 50525000
Return on net tangible assets (%): 11.434151507882266
Buffett classification: The Gruesome
Stock price: 33.95
P/E ratio: 11.816425299448303
Shares outstanding: 16592071
Book value: 460719000
P/B ratio: 1.222655914885212
Market cap (USD): 563300810.45
Debt to equity: 0.2876677540973999
Effective tax rate (%): 22.297925054196348
COGS to revenue (%): 0
SG&A to revenue (%): 39.19812289191963
Free cash flow (dilution-adjusted): 31671000
Buyback yield (%): 0
Retained earnings: 121697000
Receivables turnover: 6.602439969016267
Capitalized R&D asset: 0
FCF margin (%): 18.578090629124507
Revenue growth (%): 15.92443746302454
Rule of 40 score: 34.50252809214905
Financial ratios for TCBX — quarterly report dated 2025-03-31
Total revenue: 45635000
Net income: 13589000
Capital expenditures: 490000
Operating cash flow: 10475000
Depreciation & amortization: 1199000
Net tangible assets: 460985000
Owner earnings: 14298000
Return on net tangible assets (%): 3.1016193585474583
Buffett classification: The Gruesome
Stock price: 33.37
P/E ratio: 10.186132336264626
Shares outstanding: 16592071
Book value: 479786000
P/B ratio: 1.154009098368856
Market cap (USD): 553677409.27
Debt to equity: 0.2753519277344483
Effective tax rate (%): 21.659172143433643
COGS to revenue (%): 0
SG&A to revenue (%): 41.08688506628685
Free cash flow (dilution-adjusted): 9653000
Buyback yield (%): 0
Retained earnings: 134115000
Receivables turnover: 1.7058537679425838
Capitalized R&D asset: 0
FCF margin (%): 21.1526240823929
Rule of 40 score: 21.1526240823929
Financial ratios for TCBX — quarterly report dated 2025-06-30
Total revenue: 51585000
Net income: 16747000
Capital expenditures: 258000
Operating cash flow: 13879000
Depreciation & amortization: 1174000
Net tangible assets: 477354000
Owner earnings: 17663000
Return on net tangible assets (%): 3.7001889582992913
Buffett classification: The Gruesome
Stock price: 32.67
P/E ratio: 17.86863658920095
Shares outstanding: 16592071
Book value: 496115000
P/B ratio: 1.0926155419005674
Market cap (USD): 542062959.57
Debt to equity: 0.2652046400532135
Effective tax rate (%): 20.434245534017485
COGS to revenue (%): 0
SG&A to revenue (%): 36.21595425026655
Free cash flow (dilution-adjusted): 13215000
Buyback yield (%): 0
Retained earnings: 149677000
Receivables turnover: 1.8598572252668013
Capitalized R&D asset: 0
FCF margin (%): 25.617912183774354
Revenue growth (%): 13.038238194368358
Rule of 40 score: 38.65615037814271
Financial ratios for TCBX — quarterly report dated 2025-09-30
Total revenue: 54455000
Net income: 18057000
Capital expenditures: 832000
Operating cash flow: 20745000
Depreciation & amortization: 1186000
Net tangible assets: 495110000
Owner earnings: 18411000
Return on net tangible assets (%): 3.7185675910403746
Buffett classification: The Gruesome
Stock price: 37.97
P/E ratio: 13.018431092720022
Shares outstanding: 16592071
Book value: 513830000
P/B ratio: 1.2260882701866376
Market cap (USD): 630000935.87
Debt to equity: 0.25791214993285716
Effective tax rate (%): 20.90323711069254
COGS to revenue (%): 0
SG&A to revenue (%): 36.835919566614635
Free cash flow (dilution-adjusted): 19493000
Buyback yield (%): 0
Retained earnings: 166537000
Receivables turnover: 1.8436198666079833
Capitalized R&D asset: 0
FCF margin (%): 35.79652924433018
Revenue growth (%): 5.563632839003587
Rule of 40 score: 41.36016208333377
Financial ratios for TCBX — quarterly report dated 2025-12-31
Total revenue: 56061000
Net income: 17898000
Capital expenditures: 1101000
Operating cash flow: 5738000
Depreciation & amortization: 1188000
Net tangible assets: 512347000
Owner earnings: 17985000
Return on net tangible assets (%): 3.510316250509908
Buffett classification: The Gruesome
Stock price: 38.01
P/E ratio: 9.513578294338597
Shares outstanding: 16592071
Book value: 531027000
P/B ratio: 1.1876319258907737
Market cap (USD): 630664618.7099999
Debt to equity: 0.257934154007235
Effective tax rate (%): 16.838583774742126
COGS to revenue (%): 0
SG&A to revenue (%): 38.96113162448048
Free cash flow (dilution-adjusted): 4187000
Buyback yield (%): 0
Retained earnings: 183238000
Receivables turnover: 1.9175331782733616
Capitalized R&D asset: 0
FCF margin (%): 7.468650220295749
Revenue growth (%): 2.9492241300156095
Rule of 40 score: 10.417874350311358
Financial ratios for TCBX — annual report dated 2025-12-31
Total revenue: 207736000
Net income: 66291000
Capital expenditures: 2681000
Operating cash flow: 50837000
Depreciation & amortization: 4747000
Net tangible assets: 512347000
Owner earnings: 68357000
Return on net tangible assets (%): 13.341934275012834
Buffett classification: The Gruesome
Stock price: 38.01
P/E ratio: 9.513578294338597
Shares outstanding: 16592071
Book value: 531027000
P/B ratio: 1.1876319258907737
Market cap (USD): 630664618.7099999
Debt to equity: 0.257934154007235
Effective tax rate (%): 19.885189437428245
COGS to revenue (%): 0
SG&A to revenue (%): 38.189336465513925
Free cash flow (dilution-adjusted): 46548000
Buyback yield (%): 0
Retained earnings: 183238000
Receivables turnover: 7.1054863866466
Capitalized R&D asset: 0
FCF margin (%): 22.40728617090923
Revenue growth (%): 21.857163807009826
Rule of 40 score: 44.26444997791906
Financial ratios for TRM.AX — annual report dated 2021-06-30
Operating income: -277572.1804511278
Net income: -228794.73684210525
Capital expenditures: 11111.278195488721
Depreciation & amortization: 36.090225563909776
Net tangible assets: 2623519.5488721803
Owner earnings: -239869.92481203008
Return on net tangible assets (%): -9.143058412320476
Buffett classification: The Gruesome
Stock price: 0.022556390977443608
Shares outstanding: 217988560
Book value: 2623519.5488721803
P/B ratio: 1.8742132834816112
Market cap (USD): 4917035.187969925
Debt to equity: 0.056315326853870466
Current ratio: 2.9601218838831063
Quick ratio: 2.9601218838831063
Free cash flow (dilution-adjusted): -95135.33834586466
Buyback yield (%): 0.2547687211965007
Retained earnings: -4277718.045112782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.645310097385957
Rule of 40 score: 0
Financial ratios for TRM.AX — annual report dated 2022-06-30
Operating income: -224371.72413793104
Net income: -1842655.1724137932
Capital expenditures: 1816.5517241379312
Depreciation & amortization: 526.2068965517242
Net tangible assets: 773874.4827586208
Owner earnings: -1843945.5172413795
Return on net tangible assets (%): -238.27449519569242
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 217988560
Book value: 730475.1724137932
P/B ratio: 10.290352335607714
Market cap (USD): 7516846.896551724
Debt to equity: 0.15625162270378562
Current ratio: 3.7111407892469415
Quick ratio: 3.7111407892469415
Free cash flow (dilution-adjusted): -117144.1379310345
Buyback yield (%): 0.1360530112222403
Retained earnings: -5825548.275862069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.00722808136999
Rule of 40 score: 0
Financial ratios for TRM.AX — annual report dated 2023-06-30
Operating income: -341033.11258278147
Net income: -340595.3642384106
Capital expenditures: 188205.29801324502
Depreciation & amortization: 455.6291390728477
Net tangible assets: 798815.8940397351
Owner earnings: -528345.0331125828
Return on net tangible assets (%): -66.14102661886965
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 217988560
Book value: 798815.8940397352
P/B ratio: 7.2288639144694296
Market cap (USD): 5774531.390728476
Debt to equity: 0.2574174357409808
Current ratio: 0.13750147309449562
Quick ratio: 0.13750147309449562
Free cash flow (dilution-adjusted): -323390.7284768212
Buyback yield (%): 0.24586152594429728
Retained earnings: -5850845.695364239
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.692329374935746
Rule of 40 score: 0
Financial ratios for UBI.AX — annual report dated 2021-12-31
Total revenue: 4186776.086956522
Gross profit: 1525865.2173913044
Operating income: -7961985.507246378
Net income: -7613721.014492754
Capital expenditures: 481582.6086956522
Operating cash flow: -7171463.768115942
Depreciation & amortization: 1859941.3043478262
Net tangible assets: 10838218.11594203
Owner earnings: -6235362.31884058
Return on net tangible assets (%): -57.53124962182604
Buffett classification: The Gruesome
Stock price: 0.7173913043478262
Shares outstanding: 298067435
Book value: 20005673.188405797
P/B ratio: 10.688517400263528
Market cap (USD): 213830985.9782609
Debt to equity: 0.08171232877456609
Current ratio: 2.6430625612564898
Quick ratio: 2.4150803041672226
COGS to revenue (%): 63.555127245878204
R&D to revenue (%): 160.64949839479064
SG&A to revenue (%): 97.01165730402712
Free cash flow (dilution-adjusted): -7720026.086956522
Buyback yield (%): 0
Retained earnings: -47698718.11594203
Inventory turnover: 1.713109469354851
Receivables turnover: 1.3210192177939672
Capitalized R&D asset: 6726034.782608696
ROCI (R&D-adjusted, %): -10.814306518806186
FCF margin (%): -184.39070842616792
Rule of 40 score: -184.39070842616792
Financial ratios for UBI.AX — annual report dated 2022-12-31
Total revenue: 3057406.756756757
Gross profit: 1445291.2162162163
Operating income: -12890836.486486487
Net income: -18144967.56756757
Capital expenditures: 1057529.7297297297
Operating cash flow: -9933887.162162162
Depreciation & amortization: 1882185.810810811
Net tangible assets: 17629372.2972973
Owner earnings: -17320311.486486487
Return on net tangible assets (%): -98.24689838300033
Buffett classification: The Gruesome
Stock price: 0.14864864864864866
Shares outstanding: 298067435
Book value: 17629372.2972973
P/B ratio: 2.5132671017283768
Market cap (USD): 44307321.41891892
Debt to equity: 0.18507415699176177
Current ratio: 2.802494679046651
Quick ratio: 2.5623683135212474
Interest coverage ratio: -1051.0956972067654
COGS to revenue (%): 52.72819970642847
R&D to revenue (%): 271.64316518017165
SG&A to revenue (%): 242.7493534752336
Free cash flow (dilution-adjusted): -11207229.054054054
Buyback yield (%): 0
Retained earnings: -62620799.324324325
Inventory turnover: 0.7593232216730991
Receivables turnover: 0.7924031627045883
Capitalized R&D asset: 12811679.790834313
ROCI (R&D-adjusted, %): -27.300834290605703
Rosenberg metric: -0.011979420829554116
FCF margin (%): -366.5599622715063
Revenue growth (%): -26.974677096255544
Rule of 40 score: -393.5346393677619
Financial ratios for UBI.AX — annual report dated 2023-12-31
Total revenue: 4543039.726027397
Gross profit: 2934888.3561643837
Operating income: -9016706.164383562
Net income: -4617509.589041096
Capital expenditures: 1009155.4794520548
Operating cash flow: -10013043.835616438
Depreciation & amortization: 664158.2191780822
Net tangible assets: 13361513.01369863
Owner earnings: -4962506.849315069
Return on net tangible assets (%): -37.14030622301049
Buffett classification: The Gruesome
Stock price: 0.13698630136986303
Shares outstanding: 298067435
Book value: 13361513.013698632
P/B ratio: 3.0558781357762936
Market cap (USD): 40831155.47945206
Debt to equity: 0.25484584147814854
Current ratio: 3.698624009510248
Quick ratio: 2.9627072066991302
Interest coverage ratio: -645.7564505052487
COGS to revenue (%): 35.398135760288426
R&D to revenue (%): 74.9971128497334
SG&A to revenue (%): 226.66837332677204
Free cash flow (dilution-adjusted): -11158059.589041095
Buyback yield (%): 0.0496196439574152
Retained earnings: -68096128.08219178
Inventory turnover: 0.53630354781583
Receivables turnover: 1.124239746718684
Capitalized R&D asset: 11191248.554343805
ROCI (R&D-adjusted, %): -42.522254518222105
Rosenberg metric: 0.17935637863797163
FCF margin (%): -245.6077926221023
Revenue growth (%): 48.59127644653255
Rule of 40 score: -197.01651617556973
Financial ratios for UBI.AX — quarterly report dated 2024-09-30
Total revenue: 1287483.448275862
Gross profit: 537106.2068965518
Operating income: -2454103.4482758623
Net income: -2351301.379310345
Capital expenditures: 175837.93103448275
Operating cash flow: -2323668.9655172415
Depreciation & amortization: 113917.93103448277
Net tangible assets: 14417144.827586208
Owner earnings: -2413221.379310345
Return on net tangible assets (%): -16.73855266191689
Buffett classification: The Gruesome
Stock price: 0.10344827586206896
Shares outstanding: 298067435
Book value: 14417144.827586208
P/B ratio: 2.138742629704289
Market cap (USD): 30834562.24137931
Debt to equity: 0.1617824276268772
Current ratio: 5.026328842511855
Quick ratio: 3.7527908966358403
Interest coverage ratio: -536.4767073722297
COGS to revenue (%): 58.282476748278256
R&D to revenue (%): 55.68644739189149
SG&A to revenue (%): 192.019020264606
Free cash flow (dilution-adjusted): -2523238.620689655
Buyback yield (%): 0
Retained earnings: -75905247.5862069
Inventory turnover: 0.19765426494228036
Receivables turnover: 0.668968287584004
Capitalized R&D asset: 716953.7931034483
ROCI (R&D-adjusted, %): -11.093977073772711
FCF margin (%): -195.98221818452572
Rule of 40 score: -195.98221818452572
Financial ratios for UBI.AX — quarterly report dated 2024-12-31
Total revenue: 820379.50310559
Gross profit: 729967.701863354
Operating income: -2333263.9751552795
Net income: -2234460.248447205
Capital expenditures: 28618.012422360247
Operating cash flow: -2333321.7391304346
Depreciation & amortization: 100857.76397515528
Net tangible assets: 10789709.937888198
Owner earnings: -2162220.49689441
Return on net tangible assets (%): -20.039653608311994
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 298067435
Book value: 10789709.937888198
P/B ratio: 1.715848283788678
Market cap (USD): 18513505.279503107
Debt to equity: 0.2308243654970779
Current ratio: 3.963206769557929
Quick ratio: 2.764806477094902
Interest coverage ratio: -6684.261565836299
COGS to revenue (%): 11.020728930937128
R&D to revenue (%): 86.2645753253115
SG&A to revenue (%): 354.9377617236683
Free cash flow (dilution-adjusted): -2351266.4596273294
Buyback yield (%): 0
Retained earnings: -70596329.19254658
Inventory turnover: 0.02605916432653415
Receivables turnover: 0.42001136514322657
Capitalized R&D asset: 1188055.9357892484
ROCI (R&D-adjusted, %): -14.644302199701093
Rosenberg metric: 0.26900128965350834
FCF margin (%): -286.6071678688321
Revenue growth (%): -36.28038448150894
Rule of 40 score: -322.887552350341
Financial ratios for UBI.AX — annual report dated 2024-12-31
Total revenue: 3902321.7391304346
Gross profit: 2485859.00621118
Operating income: -9170089.440993788
Net income: -8844560.869565217
Capital expenditures: 256352.17391304346
Operating cash flow: -7639891.304347825
Depreciation & amortization: 498924.84472049685
Net tangible assets: 10789709.937888198
Owner earnings: -8601988.198757764
Return on net tangible assets (%): -79.72399859009906
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 298067435
Book value: 10789709.937888198
P/B ratio: 1.715848283788678
Market cap (USD): 18513505.279503107
Debt to equity: 0.2308243654970779
Current ratio: 3.963206769557929
Quick ratio: 2.764806477094902
Interest coverage ratio: -718.7150228799533
COGS to revenue (%): 36.297948442223756
R&D to revenue (%): 66.10665604709284
SG&A to revenue (%): 254.89078169422314
Free cash flow (dilution-adjusted): -7959424.223602484
Buyback yield (%): 0
Retained earnings: -70596329.19254658
Inventory turnover: 0.408263463534571
Receivables turnover: 1.997879608980562
Capitalized R&D asset: 7603212.032670209
ROCI (R&D-adjusted, %): -54.69827300668825
Rosenberg metric: -0.13179036158899546
FCF margin (%): -203.96637580621694
Revenue growth (%): -14.10328822850137
Rule of 40 score: -218.0696640347183
Financial ratios for UBI.AX — quarterly report dated 2025-03-31
Total revenue: 977772.9559748428
Gross profit: 530405.0314465408
Operating income: -2592284.2767295595
Net income: -2413805.0314465407
Capital expenditures: 19259.119496855346
Operating cash flow: -2339159.748427673
Depreciation & amortization: 102647.79874213836
Net tangible assets: 8508020.125786163
Owner earnings: -2330416.352201258
Return on net tangible assets (%): -27.39081851884925
Buffett classification: The Gruesome
Stock price: 0.04402515723270441
Shares outstanding: 298067435
Book value: 8508020.125786163
P/B ratio: 1.542364204340825
Market cap (USD): 13122465.6918239
Debt to equity: 0.2627484596110278
Current ratio: 2.987498652660101
Quick ratio: 1.8130798970592978
Interest coverage ratio: -1843.3506261180678
COGS to revenue (%): 45.75376336547114
R&D to revenue (%): 51.16897017288036
SG&A to revenue (%): 279.3629985739638
Free cash flow (dilution-adjusted): -2358418.867924528
Buyback yield (%): 0
Retained earnings: -73898138.36477987
Inventory turnover: 0.11913121960966046
Receivables turnover: 0.4483774118189946
Capitalized R&D asset: 1211068.0231800543
ROCI (R&D-adjusted, %): -22.646948660846157
Rosenberg metric: -0.2819889023014635
FCF margin (%): -241.2031191405961
Revenue growth (%): 19.185444330755647
Rule of 40 score: -222.01767480984046
Financial ratios for VPBN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.57142857142857
Shares outstanding: 5681585
Market cap (USD): 469136590
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VPBN.SW — annual report dated 2022-12-31
Total revenue: 365609782.6086956
Net income: 43652173.91304348
Capital expenditures: 35492391.30434783
Operating cash flow: 160700000
Depreciation & amortization: 44531521.73913043
Net tangible assets: 1099427173.9130435
Owner earnings: 52691304.34782608
Return on net tangible assets (%): 4.792614335726212
Buffett classification: The Gruesome
Stock price: 78.16304347826086
P/E ratio: 10.173375930029879
Shares outstanding: 5681585
Book value: 1197961956.52174
P/B ratio: 0.37070457284790714
Market cap (USD): 444089975.38043475
Debt to equity: 0.268808891913349
Effective tax rate (%): 11.130781146271298
COGS to revenue (%): 0
SG&A to revenue (%): 21.401113684404553
Free cash flow (dilution-adjusted): 125207608.69565217
Buyback yield (%): 0.004160927265637014
Retained earnings: 1243178260.8695652
Receivables turnover: 0.11909037543309808
Capitalized R&D asset: 0
FCF margin (%): 34.24624138945954
Rule of 40 score: 34.24624138945954
Financial ratios for VPBN.SW — annual report dated 2023-12-31
Total revenue: 433552380.95238096
Net income: 52629761.9047619
Capital expenditures: 22457142.85714286
Operating cash flow: -440211904.7619048
Depreciation & amortization: 54652380.952380955
Net tangible assets: 1224959523.8095238
Owner earnings: 84825000
Return on net tangible assets (%): 6.924718601003338
Buffett classification: The Gruesome
Stock price: 89.97619047619048
P/E ratio: 9.7132754484381
Shares outstanding: 5681585
Book value: 1318038095.2380943
P/B ratio: 0.3878547790185994
Market cap (USD): 511207374.1666667
Debt to equity: 0.2782210572712692
Effective tax rate (%): 13.150501935052944
COGS to revenue (%): 0
SG&A to revenue (%): 22.15857917975529
Free cash flow (dilution-adjusted): -462669047.61904764
Buyback yield (%): 0.0030273801314816013
Retained earnings: 1377679761.904762
Receivables turnover: 0.14993449855369842
Capitalized R&D asset: 0
FCF margin (%): -106.71583595105771
Revenue growth (%): 18.583364443615793
Rule of 40 score: -88.13247150744192
Financial ratios for VPBN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1163504444.4444444
Buffett classification: The Gruesome
Stock price: 78.32222222222221
Shares outstanding: 5681585
Book value: 1240882222.2222233
P/B ratio: 0.3586112807285852
Market cap (USD): 444994362.94444436
Debt to equity: 0.18309374871283318
Buyback yield (%): 0
Retained earnings: 1272035555.5555556
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VPBN.SW — annual report dated 2024-12-31
Total revenue: 367711111.1111111
Net income: 20523333.333333332
Capital expenditures: 14038888.888888888
Operating cash flow: -1113073333.3333333
Depreciation & amortization: 41064444.44444444
Net tangible assets: 1163504444.4444444
Owner earnings: 47548888.88888889
Return on net tangible assets (%): 4.086695939661215
Buffett classification: The Gruesome
Stock price: 78.32222222222221
P/E ratio: 21.682362982513126
Shares outstanding: 5681585
Book value: 1240882222.2222233
P/B ratio: 0.3586112807285852
Market cap (USD): 444994362.94444436
Debt to equity: 0.18309374871283318
Effective tax rate (%): 17.051374169211424
COGS to revenue (%): 0
SG&A to revenue (%): 24.37783283978969
Free cash flow (dilution-adjusted): -1127112222.222222
Buyback yield (%): 0.001997528424870997
Retained earnings: 1272035555.5555556
Receivables turnover: 0.13494849619323235
Capitalized R&D asset: 0
FCF margin (%): -306.52112165347194
Revenue growth (%): -15.186462520777045
Rule of 40 score: -321.707584174249
Financial ratios for VPBN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1325670000
Buffett classification: The Gruesome
Stock price: 97.2375
Shares outstanding: 5681585
Book value: 1408576250
P/B ratio: 0.3922138552581019
Market cap (USD): 552463121.4375
Debt to equity: 0.19416857979821825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WALD — annual report dated 2021-12-31
Total revenue: 192529729.72972974
Gross profit: 118155405.4054054
Operating income: -2195945.945945946
Net income: -26454054.054054055
Capital expenditures: 1739189.189189189
Operating cash flow: 4768918.918918919
Depreciation & amortization: 18783783.783783782
Owner earnings: -9409459.459459461
Buffett classification: The Gruesome
Stock price: 9.95
Shares outstanding: 118239889
Market cap (USD): 1176486895.55
Interest coverage ratio: -0.14615938118366614
COGS to revenue (%): 38.63004660564883
R&D to revenue (%): 4.275927901622775
SG&A to revenue (%): 58.2346004829019
Free cash flow (dilution-adjusted): 3029729.7297297297
Buyback yield (%): 0
Capitalized R&D asset: 8232432.432432433
ROCI (R&D-adjusted, %): 39.992339680455245
FCF margin (%): 1.573642540288618
Rule of 40 score: 1.573642540288618